3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Breast
1
Conditions
Glioma
4
Glioblastoma
4
Astrocytoma
3
Neoplasms
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Epstein-Barr Virus Infections
2
Breast Neoplasms
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mesothelioma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
Carboplatin
7
Paclitaxel
6
Talc
5
Docetaxel
5
Bevacizumab
4
Taxes
3
Gemcitabine
3
Cisplatin
3
Trastuzumab
2
High-Energy Shock Waves
2
Erlotinib Hydrochloride
2
Doxycycline
2
Cetuximab
2
Bortezomib
2
viscum album peptide
1
tipifarnib
1
saracatinib
1
romidepsin
1
endostar protein
1
Zoledronic Acid
1
Vinorelbine
1
Valacyclovir
1
Tyrosine Kinase Inhibitors
1
Thoracoscopy
1
Thoracoscopes
1
Thoracic Surgery, Video-Assisted
1
Thoracentesis
1
Surveys and Questionnaires
1
Sorafenib
1
Povidone-Iodine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pleural Effusion, Malignant
×
Valacyclovir
×
Clear all
NCT01997190
2023-08-25
MpeTK01
Candel Therapeutics, Inc.
Phase 1
Completed
19 enrolled